1. Ersu B. Custom-made mold brachytherapy. Basal Cell Carcinoma 2012; doi: 10.5772/26589.
2.
Delishaj D, Rembielak A, Manfredi B et al. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of the literature. J Contemp Brachytherapy 2016; 8: 533-540.
3.
Siegel RL, Miller KD, Fuchs HE et al. Cancer statistics, 2021. CA Cancer J Clin 2021; 71: 7-33.
4.
Alam M, Nanda S, Mittal BB et al. The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review. J Am Acad Dermatol 2011; 65: 377-388.
5.
Guinot JL, Rembielak A, Perez-Calatayud J et al. GEC- ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol 2018; 126: 377-385.
6.
Tagliaferri L, Ciardo FG, Fionda B et al. Non-melanoma skin cancer treated by contact high-dose-rate radiotherapy (brachytherapy): a mono-institutional series and literature review. In vivo 2021; 35: 2313-2319.
7.
Jumeau R, Renard-Oldrini S, Courrech F et al. High dose rate brachytherapy with customized applicators for malignant facial skin lesions. Cancer Radiother 2016; 20: 341-346.
8.
Fulkerson RK, Perez-Calatayud J, Ballester F et al. Surface brachytherapy: joint report of the AAPM and the GEC- ESTRO Task Group No. 253. Med Phys 2020; 47: e951-987.
9.
Bellis R, Rembielak A, Barnes EA et al. Additive manufacturing (3D printing) in superficial brachytherapy. J Contemp Brachytherapy 2021; 13: 468-482.
10.
Lloyd S, Alektiar KM, Nag S et al. Intraoperative high-dose-rate brachytherapy: An American Brachytherapy Society consensus report. Brachytherapy 2017; 16: 446-465.
11.
Jones EL, Baldion AT, Thomas C et al. Introduction of novel 3D-printed superficial applicators for high-dose-rate skin brachytherapy. Brachytherapy 2017; 16: 409-414.
12.
Granero D, Perez-Calatayud J, Vijande J et al. Limitations of the TG-43 formalism for skin high-dose-rate brachytherapy dose calculations. Med Phys 2014; 41: 021703.
13.
Micka JA, DeWerd LA. Dosimetric characterization and output verification for conical brachytherapy surface applicators. Part I. Electronic brachytherapy source. Med Phys 2014; 41.
14.
Guix B, Finestres F, Tello JI et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys 2000; 47: 95-102.
15.
Jaberi R, Siavashpour Z, Akha NZ et al. Validation of an individualized home-made superficial brachytherapy mold applied for deep nonmelanoma skin cancer. Rep Pract Oncol Radiother 2022; 27: 1010-1018.
16.
Borca VC, Pasquino M, Russo G et al. Dosimetric characterization and use of GAFCHROMIC EBT3 film for IMRT dose verification. J Appl Clin Med Phys 2013; 14: 158-171.
17.
Casolaro P, Campajola L, Breglio G et al. Real-time dosimetry with radiochromic films. Sci Rep 2019; 9: 5307.
18.
Niroomand-Rad A, Blackwell CR, Coursey BM et al. Radiochromic film dosimetry: recommendations of AAPM radiation therapy committee task group 55. Med Phys 1998; 25: 2093-2115.
19.
Semwal MK. Khan’s the physics of radiation therapy. J Med Phys 2020; 45: 134.
20.
Siavashpour Z, Kiarad R, Aghamiri MR et al. Feasibility of using micro silica bead TLDs for in-vivo dosimetry of CT-based HDR prostate brachytherapy: An experimental and simulation study. Appl Radiat Isot 2024; 212: 111429.
21.
Budrukkar A, Dasgupta A, Pandit P et al. Clinical outcomes with high-dose-rate surface mould brachytherapy for intra-oral and skin malignancies involving head and neck region. J Contemp Brachytherapy 2017; 9: 242-250.
22.
Scherf C, Licher J, Mletzko C et al. Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view. J Contemp Brachytherapy 2021; 13: 179-187.
23.
Vavassori A, Riva G, Durante S et al. Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma. J Contemp Brachytherapy 2019; 11: 443-448.
24.
Likhacheva A. Skin brachytherapy. In: Handbook of Image- Guided Brachytherapy. J. Mayadev, S.H. Benedict, M. Kamrava (Eds.). Springer International Publishing, Cham 2017; 457-480.
25.
Thatcher TR. HDR Brachytherapy for Skin Cancer Using HAM Applicator (Doctoral dissertation, University of Nevada, Las Vegas).
26.
Casey S, Awotwi-Pratt J, Bahl G. Surface mould brachytherapy for skin cancers: The British Columbia cancer experience. Cureus 2019; 11.
27.
Olek Jr D, El-Ghamry MN, Deb N et al. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer – an analysis of 273 lesions. Brachytherapy 2018; 17: 601-608.
28.
Diefenhardt M, Chatzikonstantinou G, Meissner M et al. HDR brachytherapy with individual epithetic molds for facial skin cancer: techniques and first clinical experience. Int J Dermatol 2021; 60: 717-723.
29.
Amoush A, Luckstead M, Lamba M et al. A comparison of HDR near source dosimetry using a treatment planning system, Monte Carlo simulation, and radiochromic film. Med Dosim 2013; 38: 160-164.
30.
Vijande J, Ballester F, Ouhib Z et al. Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy. Brachytherapy 2012; 11: 528-535.
31.
Aldelaijan S, Bekerat H, Buzurovic I et al. Dose comparison between TG-43-based calculations and radiochromic film measurements of the Freiburg flap applicator used for high-dose-rate brachytherapy treatments of skin lesions. Brachytherapy 2017; 16: 1065-1072.
32.
Chiu-Tsao S, Massillon-Jl G, Domingo-Muñoz I, Chan M. SU-E- T-96: Energy Dependence of the New GafChromic-EBT3 Film’s Dose Response-Curve. Med Phys 2012; 39 (6 Part 11): 3724.
33.
Zwierzchowski G, Bielęda G, Szymbor A et al. Personalized superficial HDR brachytherapy – dosimetric verification of dose distribution with lead shielding of critical organs in the head and neck region. J Pers Med 2022; 12: 1432.
34.
Raina S, Avadhani JS, Oh M et al. Quantifying IOHDR brachytherapy underdosage resulting from an incomplete scatter environment. IJROBP 2005; 61: 1582-1586.
35.
Park SY, Kang S, Park JM et al. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy. Brachytherapy 2019; 18: 224-232.
36.
Ricotti R, Vavassori A, Bazani A et al. 3D-printed applicators for high dose rate brachytherapy: Dosimetric assessment at different infill percentage. Phys Med 2016; 32: 1698-1706.
37.
Rooney MK, Rosenberg DM, Braunstein S et al. Three-dimensional printing in radiation oncology: a systematic review of the literature. J Appl Clin Med Phys 2020; 21: 15-26.
38.
Arenas M, Sabater S, Sintas A et al. Individualized 3D scanning and printing for non-melanoma skin cancer brachytherapy: a financial study for its integration into clinical workflow. J Contemp Brachytherapy 2017; 9: 270-276.